Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Ara

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|October 21, 2017
Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical StudiesRoberta Ara, John Brazier, Tracey Young
Pharmacoeconomics|October 21, 2017
The Use of Health State Utility Values in Decision ModelsRoberta Ara, John Brazier, Ismail Azzabi Zouraq
Current Opinion in Lipidology|May 24, 2012
Principles of health economic evaluations of lipid-lowering strategiesRoberta Ara, Hasan Basarir, Sue Elizabeth Ward
Pharmacoeconomics|April 24, 2008
Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health StatesNick Bansback, Roberta Ara, Jonathan Karnon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility valuesMónica Hernández Alava, Allan J Wailoo, Roberta Ara
BMC Public Health|October 26, 2013
Association between body mass index and health-related quality of life, and the impact of self-reported long-term conditions - cross-sectional study from the south Yorkshire cohort datasetBenjamin Kearns, Roberta Ara, Tracey Young, et al.
Pharmacoeconomics|October 21, 2017
The Identification, Review and Synthesis of Health State Utility Values from the LiteratureRoberta Ara, John Brazier, Tessa Peasgood, et al.
Pharmacoeconomics|October 21, 2017
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness ModelsJohn Brazier, Roberta Ara, Donna Rowen, et al.
Pharmacoeconomics|October 21, 2017
The Role of Condition-Specific Preference-Based Measures in Health Technology AssessmentDonna Rowen, John Brazier, Roberta Ara, et al.
BMC Research Notes|July 9, 2014
Predicting preference-based utility values using partial proportional odds modelsRoberta Ara, Ben Kearns, Ben A vanHout, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|October 21, 2017
Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical StudiesRoberta Ara, John Brazier, Tracey Young
Pharmacoeconomics|October 21, 2017
The Use of Health State Utility Values in Decision ModelsRoberta Ara, John Brazier, Ismail Azzabi Zouraq
Current Opinion in Lipidology|May 24, 2012
Principles of health economic evaluations of lipid-lowering strategiesRoberta Ara, Hasan Basarir, Sue Elizabeth Ward
Pharmacoeconomics|April 24, 2008
Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health StatesNick Bansback, Roberta Ara, Jonathan Karnon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility valuesMónica Hernández Alava, Allan J Wailoo, Roberta Ara
BMC Public Health|October 26, 2013
Association between body mass index and health-related quality of life, and the impact of self-reported long-term conditions - cross-sectional study from the south Yorkshire cohort datasetBenjamin Kearns, Roberta Ara, Tracey Young, et al.
Pharmacoeconomics|October 21, 2017
The Identification, Review and Synthesis of Health State Utility Values from the LiteratureRoberta Ara, John Brazier, Tessa Peasgood, et al.
Pharmacoeconomics|October 21, 2017
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness ModelsJohn Brazier, Roberta Ara, Donna Rowen, et al.
Pharmacoeconomics|October 21, 2017
The Role of Condition-Specific Preference-Based Measures in Health Technology AssessmentDonna Rowen, John Brazier, Roberta Ara, et al.
BMC Research Notes|July 9, 2014
Predicting preference-based utility values using partial proportional odds modelsRoberta Ara, Ben Kearns, Ben A vanHout, et al.
Pageof 4